Drug Shortage Report for VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
Report ID | 177097 |
Drug Identification Number | 02139243 |
Brand name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
Common or Proper name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | VANCOMYCIN |
Strength(s) | 5G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 100 mL |
ATC code | J01XA |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-03-01 |
Estimated end date | 2023-04-13 |
Actual end date | 2023-03-30 |
Shortage status | Resolved |
Updated date | 2023-04-05 |
Company comments | Product is on backorder. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-04-05 | French | Compare |
v8 | 2023-04-05 | English | Compare |
v7 | 2023-03-02 | English | Compare |
v6 | 2023-02-15 | French | Compare |
v5 | 2023-02-15 | English | Compare |
v4 | 2023-02-09 | French | Compare |
v3 | 2023-02-09 | English | Compare |
v2 | 2022-12-05 | French | Compare |
v1 | 2022-12-05 | English | Compare |
Showing 1 to 9 of 9